Clinical pathway using rapid rehydration for children with gastroenteritis

S J Phin1, M E McCaskill, G J Browne

  • 1The Emergency Department, The Children's Hospital at Westmead, Westmead, New South Wales, Australia. susanp3@chw.edu.au

Insights

A rapid rehydration clinical pathway significantly reduced hospital admissions for moderately dehydrated children with acute gastroenteritis. This approach also increased the number of children discharged from the emergency department within 8 hours.

Area of Science:

  • Pediatric Emergency Medicine
  • Gastroenterology
  • Clinical Pathway Implementation

Background:

  • Acute gastroenteritis is a common cause of dehydration in children presenting to emergency departments.
  • Moderate dehydration requires effective and timely management to prevent complications and reduce healthcare resource utilization.

Purpose of the Study:

  • To evaluate the efficacy of a clinical pathway employing rapid rehydration for pediatric patients with moderate dehydration due to acute gastroenteritis.
  • To assess the impact of this pathway on emergency department admission rates and length of stay.

Main Methods:

  • Prospective study with historical controls in a pediatric emergency department.
  • Intervention involved a clinical pathway with rapid intravenous or nasogastric rehydration.
  • Compared outcomes between 145 children in the intervention group and 170 historical controls.

Main Results:

  • The intervention group showed a significantly lower admission rate (55.8% vs. 96.3%) compared to controls.
  • A higher percentage of children in the intervention group were discharged within 8 hours (44.2% vs. 3.7%).
  • No significant differences were observed in re-presentation rates or procedural rates.

Conclusions:

  • A clinical pathway utilizing rapid rehydration is effective for managing moderately dehydrated children with gastroenteritis.
  • This pathway successfully reduces emergency department admission rates and shortens patient stays.
  • Rapid rehydration strategies can optimize care for pediatric gastroenteritis.
Abstract

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Cholera01:25

Cholera

Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...